Table 3.
microRNA | Average Difference in Threshold Cyclea |
SD (Difference in Threshold Cycle) |
Fold Changeb |
P Valuec |
---|---|---|---|---|
MicroRNA Expression in Tumors vs Paired Nontumorous Tissue From the Hong Kong Validation Cohortd | ||||
miR-20a |
1.18 |
0.97 |
2.3 |
<.001 |
miR-21 |
1.47 |
1.20 |
2.8 |
<.001 |
miR-106a |
1.25 |
0.94 |
2.4 |
<.001 |
miR-181b |
0.47 |
1.03 |
1.4 |
<.001 |
miR-203 |
0.83 |
1.40 |
1.8 |
<.001 |
MicroRNA Expression in Adenoma vs Paired Nonadenoma Tissuee | ||||
miR-20a |
-0.11 |
0.97 |
0.9 |
.82 |
miR-21 |
0.64 |
0.90 |
1.6 |
.006 |
miR-106a |
0.28 |
1.22 |
1.2 |
.19 |
miR-181b |
0.30 |
1.24 |
1.2 |
.27 |
miR-203 | 0.77 | 1.98 | 1.7 | .14 |
Threshold cycle is the unit of measurement in quantitative reverse transcription polymerase chain reaction (RT-PCR) to measure relative gene expression. Average (tumor change in threshold cycle minus paired nontumor change in threshold cycle) or average (adenoma change in threshold cycle minus paired nonadenoma change in threshold cycle) from quantitative RT-PCR. Positive values indicate higher expression in tumor tissue.
Calcluated by 2average difference in threshold cycles.
Wilcoxon matched pairs test.
For the tumor/nontumor comparisons, 113 pairs of tissues were used for miR-20a and miR-203 while 111 pairs of tissue were used for miR-21, miR-106a, and miR-181b.
For all adenoma/nonadenoma comparisons, 18 pairs of tissue were used.